Roanna Ruiz Analyst PerformanceSenior Managing Director, Senior Biotechnology Analyst at Leerink PartnersRoanna Ruiz is a stock analyst at Leerink Partners focused in the medical sector, covering 12 publicly traded companies. Over the past year, Roanna Ruiz has issued 13 stock ratings, including and buy recommendations. While full access to Roanna Ruiz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Roanna Ruiz's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings23 Last 4 YearsBuy Recommendations85.00% 17 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution20RatingsDistribution of strong buy, buy, hold, and sell ratings by Roanna Ruiz.RatingPercentageCount Strong Buy0.0%0 ratings Buy85.0%17 ratings Hold15.0%3 ratings Sell0.0%0 ratingsOut of 20 total stock ratings issued by Roanna Ruiz at Leerink Partners, the majority (85.0%) have been Buy recommendations, followed by 15.0% Hold.Best & Worst CallsBest Call000.0%XERSMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%VIRJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ12 companiesRoanna Ruiz, an analyst at Leerink Partners, currently covers 12 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical11 companies91.7%Manufacturing1 company8.3%Roanna Ruiz of Leerink Partners specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE6 companies50.0%MED - DRUGS5 companies41.7%PHARMACEUTICAL PREPARATIONS1 company8.3% Roanna Ruiz's Ratings History at Leerink Partners Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCRMDCorMedix4/28/2026Boost Price Target$7.82$14.00Outperform$0.0000.00% ROIARDXArdelyx3/12/2026Set Price Target$5.66$17.00$0.0000.00% ROICYTKCytokinetics3/10/2026Reiterated Rating$63.94Outperform$0.0000.00% ROICYTKCytokinetics3/10/2026Set Price Target$64.23$84.00$0.0000.00% ROISPRYARS Pharmaceuticals3/10/2026Set Price Target$9.39$26.00Outperform$0.0000.00% ROICRMDCorMedix3/6/2026Reiterated Rating$6.46$13.00Outperform$0.0000.00% ROIVIRVir Biotechnology2/26/2026Reiterated Rating$9.35$20.00Outperform$0.0000.00% ROICYTKCytokinetics2/26/2026Boost Price Target$62.80$84.00Outperform$0.0000.00% ROINAMSNewAmsterdam Pharma1/6/2026Reiterated Rating$33.48$55.00Outperform$0.0000.00% ROICYTKCytokinetics12/22/2025Set Price Target$68.34$83.00$0.0000.00% ROITRVITrevi Therapeutics11/19/2025Boost Price Target$11.31$16.00Outperform$0.0000.00% ROIIBIOiBio10/17/2025Initiated Coverage$0.85$2.00Outperform$0.0000.00% ROIXERSXeris Biopharma8/19/2025Boost Price Target$7.59$9.00Outperform$0.0000.00% ROIAKBAAkebia Therapeutics4/28/2025Initiated Coverage$2.38$7.00Outperform$0.0000.00% ROICRMDCorMedix3/7/2025Initiated Coverage$9.49$18.00Outperform$0.0000.00% ROIXERSXeris Biopharma3/7/2025Boost Price Target$4.19$6.00Outperform$0.0000.00% ROILXRXLexicon Pharmaceuticals3/4/2025Reiterated Rating$0.32$1.00Market Perform$0.0000.00% ROIVIRVir Biotechnology1/13/2025Boost Price Target$10.71$20.00Outperform$0.0000.00% ROISPRYARS Pharmaceuticals1/13/2025Boost Price Target$11.97$27.00Outperform$00.0000.00% ROILXRXLexicon Pharmaceuticals10/18/2024Set Price Target$2.04$6.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
